Date Initiated by Firm |
December 10, 2003 |
Date Posted |
July 20, 2004 |
Recall Status1 |
Terminated 3 on November 15, 2005 |
Recall Number |
Z-0345-04 |
Recall Event ID |
27983 |
PMA Number |
P950014 |
Product Classification |
System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy - Product Code MEQ
|
Product |
Prostatron Praktis Type II for Transurethral Microwave Thermotherapy. The Prostatron is a computer-controlled device designed to deliver microwave energy to the prostrate for the treatment of BPH (Benign Prostatic Hyperplasia). The Prostatron utilizes a transurethral microwave antenna, with simultaneous urethral cooling, to heat the prostate. This heating process is regulated through feedback from a series of temperature sensors. |
Code Information |
Serial numbers PP80023 through PP80040 and PP037 through PP180 |
Recalling Firm/ Manufacturer |
Urologix, Inc. 14405 21st Ave N Minneapolis MN 55447-4685
|
For Additional Information Contact |
Tod Paulson 763-475-4100
|
Manufacturer Reason for Recall |
During treatments, using the Prostatron units, the devices' Temperature Sensing System may change the rectal temperature reading by up to 2 degrees Celsius and may briefly delay updates to the rectal temperature reading.
|
FDA Determined Cause 2 |
Other |
Action |
A letter about the problem, actions to take to avoid the problem, and the proposed software correction was sent to consignees on December 10, 2003. A software upgrade will be performed on all units in March 2004. |
Quantity in Commerce |
146 units |
Distribution |
The product was shipped to consignees located nationwide in the United States and to foreign consignees in Australia, France and Japan. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
PMA Database |
PMAs with Product Code = MEQ and Original Applicant = Urologix, Inc.
|